All Studies Meta Analysis

Role of Nigella Sativa (black cumin seeds)as an adjunct therapy in treating severe and critical COVID-19 infection compared to those with standard therapy : An open label randomized clinical trial

Faruq et al., Bangladesh Critical Care Journal, doi:10.3329/bccj.v11i2.69187

Sep 2023

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Download Image

Nigella Sativa

12th treatment shown to reduce risk in January 2021, now with p = 0.00016 from 14 studies.

Lower risk for ventilation, hospitalization, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,100+ studies for 112 treatments. c19early.org

Open label randomized trial of 150 ICU patients in Bangladesh, showing shorter ICU stay and lower requirements for increased oxygen support including mechanical ventilation with nigella sativa treatment, but no significant difference in mortality.

The large baseline difference in convalescent plasma usage suggests an error or randomization problem.

This study is excluded in the after exclusion results of meta analysis: potential data issue.

Important missing comments or errors? Let us know.

risk of death, 6.5% lower, RR 0.94, p = 0.87, treatment 29 of 75 (38.7%), control 31 of 75 (41.3%), NNT 37.

risk of mechanical ventilation, 61.9% lower, RR 0.38, p = 0.01, treatment 8 of 75 (10.7%), control 21 of 75 (28.0%), NNT 5.8, day 14.

risk of mechanical ventilation, 83.3% lower, RR 0.17, p < 0.001, treatment 3 of 75 (4.0%), control 18 of 75 (24.0%), NNT 5.0, day 7.

ICU stay, 23.5% lower, RR 0.77, p = 0.74, treatment 4 of 46 (8.7%), control 5 of 44 (11.4%), NNT 37, >28 days.

ICU stay, 28.3% lower, RR 0.72, p = 0.46, treatment 9 of 46 (19.6%), control 12 of 44 (27.3%), NNT 13, >21 days.

ICU stay, 33.6% lower, RR 0.66, p = 0.007, treatment 25 of 46 (54.3%), control 36 of 44 (81.8%), NNT 3.6, >14 days.

ICU stay, 6.6% lower, RR 0.93, p = 0.43, treatment 41 of 46 (89.1%), control 42 of 44 (95.5%), NNT 16, >7 days.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Faruq et al., 1 Sep 2023, Randomized Controlled Trial, Bangladesh, peer-reviewed, 4 authors.

This Paper Nigella Sativa All

SEE PROFILE

Mohammad Omar Faruq, Karishma Shamarukh, Samira Humaira Habib, Amina Sultana, Umme Kulsum Chy, Chowdhury Tasneem Hasin, Mohammed Salah Uddin, Samira Humaira Habib, Susmita Hossain, Yasmin Tamanna, Shena, Tasmia Kashfi, Md Gisan Hossain, Md Rashedul Haque Khan, Razibul Hasan, MD Saifuddin Sujhon, Mehnaz Ferdous, Syed Mahfuzur Rahman, Ahmed Sayeed Arefin, Mir Atiqur Rahman, Shamsi Islam

doi:10.3329/bccj.v11i2.69187

The user has requested enhancement of the

Conflict of interest: None. Funding: Self-funded. Author contribution:

References

Anwar, Hussain, Zengin, A plant with high potential for development of functional foods and nutraceuticals/ pharmaceuticals, International Journal of Pharmacology

Ashraf, Ashraf, Imran, Kalsoom, Siddiqui et al., Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial, doi:10.1101/2020.10.30.20217364

Azeiz, Darweesh, Amin, Efficacy of thymoquinone against vaginal candidiasis in prednisolone-induced immunesuppressed mice, J Am Sci

Barakat, Wakeel, Hagag, Effects of Nigella sativa on outcome of hepatitis C in Egypt, World J Gastroenterol

Bouchentouf, Missoum, Identification of Compounds from Nigella Sativaas New Potential Inhibitors of 2019 Novel Coronavirus (Covid-19): Molecular Docking Study, ChemRxiv, doi:10.26434/chemrxiv.12055716.v1

Carsana, Sonzognia, Naser, Pulmonary post mortem findings in a series of COVID -19 cases from northern Italy: a two center descriptive study, Lancet infect Dis

Chaieb, Kouidhi, Jrah, Mahdouani, Bakhrouf, Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation, BMC Complement Altern Med

Dietician, None

Elgazzar, Elmezayen, Marecki, Nicolls, Canastar et al., Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation, Int Immunopharmacol

Faiq, Ghareeb, Clinical trials of black seeds against COVID -`19 in Kirkuk city on Iraq, Ind. J. O Forens. Med. and Toxicology

Forouzanfar, Bazzaz, Hosseinzadeh, Black cumin (Nigella Sativa) and its constituent (thymoquinone): a review on antimicrobial effects, Iran J Basic Med Sci

Gali-Muhtasib, Ocker, Kuester, Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models, J Cell Mol Med

Goreja, Black seed: nature's miracle remedy

Guan, Ni, Hu, Clinical Characteristics of Corona virus Disease 2019 in China, N Engl J Med, doi:10.1056/NEJMoa2002032

Halawani, Anti-bacterial activity of thymo-quinone and thymohydroquin one of Nigella sativa L. and their interaction with some antibiotics, Adv Biol Res

Haq, Abdullatif, Lobo, Khabar, Sheth et al., Nigella Sativa: effect on human lymphocytes and polymorphonuclear leukocyte phagocytic activity, Immunopharmacology

Haq, Lobo, Al-Tufail, Rama, St, Immunomodulatory effect of Nigella sativa proteins fractionated by ionex change chromatography, Int J Immunopharmacol

Hassanien, Assiri, Alzohairy, Oraby, Health-promoting value and food applications of black cumin essential oil: an overview, J Food Sci Technol

Hosseinzadeh, Pervade, Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice, Phytomedicine

Hosseinzadeh, Taiari, Nassiri-Asl, Effect of thymoquinone, a constituent of Nigella sativa L. on ischemia-reperfusion in rat skeletal muscle, Naunyn Schmiedebergs Arch Pharmacol

Huang, Wangy, Lix, Renl, Zhaoj et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet

Khan, Chemical composition and medicinal properties of Nigella sativa Linn, Inflammo-pharmacology

Koshak, Koshak, Mobeireek, Badawima, Wali et al., Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial, Complementary Therapies in Medicine

Onifade, Jewell, Adedeji, Nigella sativa concoction induced sustained seroreversion in HIV patient, Afr J Tradit Complement Altern Med

Ralph, Lew, Zeng, Francis, Xue et al., -CoV (Wuhanvirus), a novel Corona virus: human-to-human transmission, travel-related cases, and vaccine readiness, J Infect Dev Ctries

Ramadan, Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): an overview, International Journal of Food Science & Technology

Said, Abdulbaset, El-Kholy, Besckales, Sabri, The effect of Nigella Sativa and Vitamin D3 supplementation on clinicasl outcome in COVID -19 patients: A randomized controlled clinical trial, Front Phamacol, doi:10.3389/fphar2022.1011522

Salem, Hossain, Protective effect of black seed oil from Nigella sativa against murine cytomegalo virus infection, Int J Immunopharmacol

Umar, Shah, Munir, Yaqoob, Fiaz et al., Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avain influenza virus (H9N2) in turkeys, Poult Sci

Who Director, General's opening remarks at the media brief in gon COVID-19-11

Yang, Yu, Xu, Shu, Xia et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China:a single-centered, retrospective, observational study, Lancet Resp Med

Late treatment
is less effective

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0